These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32761064)

  • 21. A splicing variant of a death domain protein that is regulated by a mitogen-activated kinase is a substrate for c-Jun N-terminal kinase in the human central nervous system.
    Zhang Y; Zhou L; Miller CA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2586-91. PubMed ID: 9482930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into the clinical and molecular spectrum of the MADD-related neurodevelopmental disorder.
    Abdel-Salam GMH; Abdel-Hamid MS
    J Hum Genet; 2024 Jun; 69(6):263-270. PubMed ID: 38459224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KIF1Bbeta- and KIF1A-mediated axonal transport of presynaptic regulator Rab3 occurs in a GTP-dependent manner through DENN/MADD.
    Niwa S; Tanaka Y; Hirokawa N
    Nat Cell Biol; 2008 Nov; 10(11):1269-79. PubMed ID: 18849981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRAIL suppresses human breast cancer cell migration via MADD/CXCR7.
    Wang R; Li JC
    Asian Pac J Cancer Prev; 2015; 16(7):2751-6. PubMed ID: 25854358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DENN/MADD/IG20 alternative splicing changes and cell death in Alzheimer's disease.
    Mo Y; Williams C; Miller CA
    J Mol Neurosci; 2012 Sep; 48(1):97-110. PubMed ID: 22678883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MADD Expression in Lung Adenocarcinoma and its Impact on Proliferation and Apoptosis of Lung Adenocarcinoma Cells.
    Ye B; Zhong F; Yu G; Lou H; Hu J
    Comb Chem High Throughput Screen; 2019; 22(3):207-215. PubMed ID: 30947659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MADD promotes the survival of human lung adenocarcinoma cells by inhibiting apoptosis.
    Bi W; Wei Y; Wu J; Sun G; Guo Y; Zhang Q; Dong L
    Oncol Rep; 2013 Apr; 29(4):1533-9. PubMed ID: 23443411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
    Wang LQ; Wong KY; Rosèn A; Chim CS
    Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotype and genotype spectrum of variants in guanine nucleotide exchange factor genes in a broad cohort of Iranian patients.
    Mosallaei M; Ehtesham N; Beheshtian M; Khoshbakht S; Davarnia B; Kahrizi K; Najmabadi H
    Mol Genet Genomic Med; 2022 Apr; 10(4):e1894. PubMed ID: 35174982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, pathological and genetic features and follow-up of 110 patients with late-onset MADD: a single-center retrospective study.
    Wen B; Tang S; Lv X; Li D; Xu J; Olsen RKJ; Zhao Y; Li W; Wang T; Shao K; Zhao D; Yan C
    Hum Mol Genet; 2022 Mar; 31(7):1115-1129. PubMed ID: 34718578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
    Gao P; Wang Z; Hu Z; Jiao X; Yao Y
    J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of MADD in lung adenocarcinoma tissues and its effects on proliferation and apoptosis of lung adenocarcinoma A549 cells].
    Wei YP; Wu JX; Guo YF; Sun GY; Zhang Q; Bi WX; Dong L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):354-7. PubMed ID: 22482404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity.
    Schütze K; Groß M; Cornils K; Wustrau K; Schneppenheim S; Lenhartz H; Korenke GC; Janka G; Ledig S; Müller I; Ehl S; Lehmberg K
    Blood Adv; 2023 Apr; 7(8):1531-1535. PubMed ID: 36206192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MADD/DENN splice variant of the IG20 gene is necessary and sufficient for cancer cell survival.
    Mulherkar N; Ramaswamy M; Mordi DC; Prabhakar BS
    Oncogene; 2006 Oct; 25(47):6252-61. PubMed ID: 16682944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variants in DOCK3 cause developmental delay and hypotonia.
    Wiltrout K; Ferrer A; van de Laar I; Namekata K; Harada T; Klee EW; Zimmerman MT; Cousin MA; Kempainen JL; Babovic-Vuksanovic D; van Slegtenhorst MA; Aarts-Tesselaar CD; Schnur RE; Andrews M; Shinawi M
    Eur J Hum Genet; 2019 Aug; 27(8):1225-1234. PubMed ID: 30976111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.
    Saini S; Sripada L; Tulla K; Kumar P; Yue F; Kunda N; Maker AV; Prabhakar BS
    Cell Death Dis; 2019 Feb; 10(2):145. PubMed ID: 30760700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IG20/MADD plays a critical role in glucose-induced insulin secretion.
    Li LC; Wang Y; Carr R; Haddad CS; Li Z; Qian L; Oberholzer J; Maker AV; Wang Q; Prabhakar BS
    Diabetes; 2014 May; 63(5):1612-23. PubMed ID: 24379354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and properties of Rab3 GEP (DENN/MADD).
    Sakisaka T; Takai Y
    Methods Enzymol; 2005; 403():254-61. PubMed ID: 16473592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs.
    Efimova EV; Al-Zoubi AM; Martinez O; Kaithamana S; Lu S; Arima T; Prabhakar BS
    Oncogene; 2004 Feb; 23(5):1076-87. PubMed ID: 14716293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells.
    Li LC; Jayaram S; Ganesh L; Qian L; Rotmensch J; Maker AV; Prabhakar BS
    Am J Obstet Gynecol; 2011 Oct; 205(4):362.e12-25. PubMed ID: 21855847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.